Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Mehling

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|October 15, 2010
Images in clinical medicine. Dissociation of voluntary and emotional innervation after strokeLudwig Kappos, Matthias Mehling
Current Opinion in Biotechnology|February 4, 2014
Microfluidic cell cultureMatthias Mehling, Savaş Tay
Current Neurology and Neuroscience Reports|July 27, 2011
Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directionsMatthias Mehling, Ludwig Kappos, Tobias Derfuss
The Neurologist|January 16, 2008
10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous systemMatthias Mehling, Jens Kuhle, Axel Regeniter
Lab on a Chip|December 17, 2014
Real-time tracking, retrieval and gene expression analysis of migrating human T cellsMatthias Mehling, Tino Frank, Cem Albayrak, et al.
Case Reports in Oncology|April 9, 2011
Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the LiteratureMarcus Vetter, Alexandar Tzankov, Andreas Engert, et al.
European Journal of Immunology|February 12, 2010
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patientsRaija L P Lindberg, Francine Hoffmann, Matthias Mehling, et al.
BMJ Case Reports|June 8, 2012
Three cases of primary small vessel vasculitis of the skeletal muscle-an own entityNadja Benz, Thomas Daikeler, Stephan Frank, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Avidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MSMatthias Mehling, Dominik Eichin, Patricia Hafner, et al.
The Lancet. Neurology|February 16, 2020
Advances in oral immunomodulating therapies in relapsing multiple sclerosisTobias Derfuss, Matthias Mehling, Athina Papadopoulou, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|October 15, 2010
Images in clinical medicine. Dissociation of voluntary and emotional innervation after strokeLudwig Kappos, Matthias Mehling
Current Opinion in Biotechnology|February 4, 2014
Microfluidic cell cultureMatthias Mehling, Savaş Tay
Current Neurology and Neuroscience Reports|July 27, 2011
Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directionsMatthias Mehling, Ludwig Kappos, Tobias Derfuss
The Neurologist|January 16, 2008
10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous systemMatthias Mehling, Jens Kuhle, Axel Regeniter
Lab on a Chip|December 17, 2014
Real-time tracking, retrieval and gene expression analysis of migrating human T cellsMatthias Mehling, Tino Frank, Cem Albayrak, et al.
Case Reports in Oncology|April 9, 2011
Hodgkin's Lymphoma and Paraneoplastic Phenomena in the Central Nervous System: A Case Report and Review of the LiteratureMarcus Vetter, Alexandar Tzankov, Andreas Engert, et al.
European Journal of Immunology|February 12, 2010
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patientsRaija L P Lindberg, Francine Hoffmann, Matthias Mehling, et al.
BMJ Case Reports|June 8, 2012
Three cases of primary small vessel vasculitis of the skeletal muscle-an own entityNadja Benz, Thomas Daikeler, Stephan Frank, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Avidity of vaccine-induced influenza IgG fails to increase in fingolimod-treated patients with MSMatthias Mehling, Dominik Eichin, Patricia Hafner, et al.
The Lancet. Neurology|February 16, 2020
Advances in oral immunomodulating therapies in relapsing multiple sclerosisTobias Derfuss, Matthias Mehling, Athina Papadopoulou, et al.
Pageof 5